Blood Advances
Publisher: Elsevier · ISSN 2473-9529 · 99 articles
- A synthetic, small-molecule, allosteric inhibitor of human factor XIa for thrombosis
- Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders
- Therapeutic timing and molecular properties influence low-molecular-weight heparin efficacy in murine sepsis
- Survival improvement of patients with DLBCL treated with third-line and beyond in the recent era in the Czech Republic
- Factors associated with recurrent episodes of acute chest syndrome in adult patients with sickle cell disease
- Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts
- Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations
- Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study
- Synthetic lethality in TP53-mutated AML